Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Gene expression profiling for individualized breast cancer chemotherapy: success or not?

Nature Clinical Practice Oncology volume 3, pages 538–539 (2006)Cite this article

boxed-textPaik S et al. (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24: 3726–3734

Background

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Paik S et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817–2826

    Article  CAS  Google Scholar 

  2. Ntzani EE and Ioannidis JP (2003) Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet 362: 1439–1444

    Article  CAS  Google Scholar 

  3. Ioannidis JP (2005) Microarrays and molecular research: noise discovery? Lancet 365: 454–455

    Article  Google Scholar 

  4. Ein-Dor L et al. (2006) Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci USA 103: 5923–5928

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Department of Hygiene and Epidemiology at the University of Ioannina School of Medicine, Ioannina, Greece

    John PA Ioannidis

  2. Tufts University School of Medicine, Boston, MA, USA

    John PA Ioannidis

Authors
  1. John PA Ioannidis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John PA Ioannidis.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ioannidis, J. Gene expression profiling for individualized breast cancer chemotherapy: success or not?. Nat Rev Clin Oncol 3, 538–539 (2006). https://doi.org/10.1038/ncponc0631

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0631

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing